Diagnostic Medical Systems S.A. (EPA:ALDMS)
France · Delayed Price · Currency is EUR 1.045
+0.010 (0.97%)
Aug 21, 2026, 4:50 PM CET
EPA:ALDMS Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 27 | 33 | 14 | 20 | 16 | 20 | |
Market Cap Growth | -5.78% | 142.32% | -32.13% | 22.82% | -17.21% | -30.68% |
Enterprise Value | 40 | 51 | 31 | 36 | 32 | 34 |
Last Close Price | 1.04 | 1.27 | 0.75 | 1.14 | 1.01 | 1.22 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 0.51 | 0.62 | 0.28 | 0.45 | 0.44 | 0.52 |
PB Ratio | 1.31 | 1.59 | 0.96 | 1.46 | 0.90 | 0.96 |
P/TBV Ratio | 2.56 | 3.11 | 3.19 | 2.84 | 1.29 | 1.41 |
P/FCF Ratio | - | - | 452.45 | - | - | - |
P/OCF Ratio | 54.60 | 66.31 | 3.77 | - | 16.96 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.76 | 0.96 | 0.64 | 0.81 | 0.85 | 0.90 |
EV/EBITDA Ratio | 18.86 | 33.94 | 17.47 | 57.18 | - | 31.00 |
EV/EBIT Ratio | 34.56 | 43.58 | - | - | - | - |
EV/FCF Ratio | - | - | 1040.72 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.91 | 0.91 | 1.42 | 1.46 | 0.85 | 0.78 |
Debt / EBITDA Ratio | 8.79 | 8.79 | 11.23 | 32.05 | - | 14.39 |
Debt / FCF Ratio | - | - | 669.13 | - | - | - |
Net Debt / Equity Ratio | 0.56 | 0.56 | 1.04 | 1.12 | 0.60 | 0.57 |
Net Debt / EBITDA Ratio | 7.76 | 7.76 | 8.24 | 24.45 | -3.24 | 10.58 |
Net Debt / FCF Ratio | -4.79 | -4.79 | 491.13 | -3.50 | -2.59 | -1.68 |
Asset Turnover | 0.91 | 0.91 | 0.93 | 0.84 | 0.69 | 0.77 |
Inventory Turnover | 2.11 | 2.11 | 1.99 | 1.93 | 1.85 | 1.96 |
Quick Ratio | 0.76 | 0.76 | 0.63 | 0.63 | 0.61 | 0.72 |
Current Ratio | 1.37 | 1.37 | 1.29 | 1.44 | 1.60 | 1.39 |
Return on Equity (ROE) | 0.28% | 0.28% | -20.20% | -61.69% | -34.50% | -13.79% |
Return on Assets (ROA) | 1.25% | 1.25% | -0.94% | -2.04% | -8.02% | -1.05% |
Return on Invested Capital (ROIC) | 1.42% | 1.50% | -2.71% | -5.89% | -22.40% | -2.66% |
Return on Capital Employed (ROCE) | 3.30% | 3.30% | -2.60% | -5.90% | -23.30% | -2.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -0.62% | -0.51% | -21.22% | -24.73% | -41.89% | -19.70% |
FCF Yield | -8.94% | -7.36% | 0.22% | -21.85% | -25.99% | -35.40% |
Buyback Yield / Dilution | -20.91% | -20.91% | -17.09% | -8.33% | - | - |